Tevogen Bio Shares Are On The Rise Monday: What's Going On?
Tevogen Bio Shares Are On The Rise Monday: What's Going On?
Moreover, the company's leadership addressed the company's depressed stock price and reassured investors of Tevogen Bio's focus on sustaining financial stability and shareholder value. Tevogen Bio shares are down more than 87% year-to-date. The stock was trading down close to $1 per share on Friday before surging more than 30% and closing Friday up nearly 10% for the session. Tevogen Bio Holdings Inc. (NASDAQ:TVGN) shares are trading higher Monday, potentially driven by momentum from a late-Friday announcement regarding operational updates. Here's what you need to know.
Tevogen Bio Holdings公司（納斯達克:TVGN）股票週一交易走高，可能受到週五晚間有關運營更新的動力推動。以下是您需要了解的內容。
What To Know: Shortly before the market close on Friday, Tevogen said it's close to finalizing a deal with CD8 Technology to establish a comprehensive, turn-key facility to support both pre-clinical research and GMP manufacturing capabilities. The facility is expected to be staffed by Tevogen, providing necessary infrastructure to advance the company's pipeline.
週五收盤前不久，Tevogen表示正在與CD8科技就建立全面的、一站式設施達成最後協議，以支持既有臨床前研究又有GMP製造能力。該設施預計將由Tevogen提供人員配備，爲推進公司的項目提供必要的基礎設施。
In connection with the announcement, Tevogen Bio highlighted an active agreement enabling access to a $36 million line of credit, which supports the company's ongoing operations and long-term growth efforts.
與此同時，Tevogen Bio強調了一項活躍的協議，使其獲得了3600萬美元的信貸額度，支持公司的正在進行的業務和長期增長努力。
Moreover, the company's leadership addressed the company's depressed stock price and reassured investors of Tevogen Bio's focus on sustaining financial stability and shareholder value. Tevogen Bio shares are down more than 87% year-to-date. The stock was trading down close to $1 per share on Friday before surging more than 30% and closing Friday up nearly 10% for the session.
此外，公司領導人談到了公司低迷的股價，並向Tevogen Bio的股東保證公司專注於維持財務穩定和股東價值。Tevogen Bio的股價今年截至目前已下跌超過87%。週五，股價在接近每股1美元的水平交易，隨後飆升超過30%，週五收盤時漲幅接近10%。
"As we prepare to file our most recent quarterly financials, I want to highlight that Tevogen Bio has the funding it needs to sustain its operations and continue executing our strategy. We remain attentive to enhancing shareholder value, which is always top of mind for our team as we work to drive long-term success," commented Kirti Desai, Tevogen Bio's CFO.
「在我們準備提交最新季度財務報告之際，我想強調Tevogen Bio已經獲得了維持運營所需資金並繼續執行我們的策略。我們始終關注增加股東價值，在促進長期成功的過程中，這總是我們團隊牢記在心的事」，Tevogen Bio的首席財務官Kirti Desai評論道。
TVGN Price Action: Tevogen Bio shares were up 12.7% at $1.37 at the time of writing, according to Benzinga Pro.
TVGN股價走勢：根據Benzinga Pro的數據，Tevogen Bio股價在撰寫本文時上漲了12.7%，至1.37美元。
- What's Going On With Shopify Stock Monday?
- shopify股票週一怎麼了？
Photo: Pixabay.
圖片來源：Pixabay。
譯文內容由第三人軟體翻譯。
